Skip to content
Open access

Performance of general-population breast cancer risk prediction models in an international consortium

Aug 2026 · medRxiv · 0 citations
Medicine

TL;DR

Existing BC risk prediction models provided similar risk discrimination across multiple cohorts, although there was overestimation of risk for high-risk individuals, which supports development of a unified risk model for diverse populations that leverages appropriate incidence rates.

Abstract

Background: Several breast cancer (BC) risk prediction models have been developed to provide personal risk assessments. Though individually validated, their performance has not been systematically evaluated across a wide range of populations or ages. Methods: We harmonized individual-level baseline questionnaire data and incident BC diagnoses from 21 cohorts from North America, Europe, and Australia participating in the Breast Cancer Risk Prediction Project. Five-year absolute risk of invasive BC was estimated for five established risk prediction models using classical risk factors only. Discrimination was evaluated by area under the curve (AUC). Calibration was assessed using average and risk-decile specific expected to observed (E/O) ratios. Performance metrics were meta-analyzed across cohorts and models. Metaregression tested associations between cohort characteristics and performance metrics. Results: This analysis included 1,595,977 women aged 20-75 years, enrolled in studies between 1976-2015, with 19,062 (1.2%) invasive BC cases ascertained within 5 years from exposure assessment. Age-adjusted AUCs were similar across models and cohorts (pooled AUCs by model: 0.57-0.58), while E/O ratios varied substantially (pooled E/O ratios by model: 0.83-1.25). Overestimation was common among predicted high-risk individuals (>3%). No appreciable differences in model performance by cohort age, birth year, race, and variable missingness emerged. Calibration improved after assigning race-specific incidence rates. Conclusion: Existing BC risk prediction models provided similar risk discrimination across multiple cohorts, although there was overestimation of risk for high-risk individuals. Performance variation across cohorts was not driven by specific characteristics, which supports development of a unified risk model for diverse populations that leverages appropriate incidence rates.

Read PDF

Similar papers

Open access Sep 2026

Development and Validation of a Competing-Risk Nomogram for Predicting Breast Cancer–Specific Survival in Young Women with Early-Stage Breast Cancer: A SEER-Based Study

Background & Objective: Breast cancer in women aged ≤40 years is biologically aggressive and carries a disproportionate cancer-specific mortality risk. Existing prognostic tools predominantly predict overall survival, rarely account for competing risks of non-cancer death, and have not evaluated whether primary treatme...

Umema Tariq, Yousaf Ali, Mohammad Idrees et al. · 0 citations
Sep 2026

Construction and Validation of a Nomogram Model for Predicting Cancer-Specific Survival in Colorectal Cancer Based on the SEER Database.

The nomogram model incorporating clinicopathological and demographic variables showed higher predictive accuracy than conventional TNM staging for CSS in CRC patients and indicated that the nomogram provided higher net benefit for prognostic risk classification than the traditional TNM staging system across a wide rang...

Yi Liu, Xiao-Jun Tang, Zhi Liu et al. · 0 citations
Open access Sep 2026

Implementation of risk prediction models using electronic health data for early detection of pancreatic cancer: a prospective pilot feasibility study

Background & AimsWe previously developed multiple machine-learning and regression-based risk prediction models using retrospective electronic health records (EHR) to estimate near-term risk of pancreatic cancer (PC). This pilot study aimed to assess the feasibility of an early detection strategy combining initial EHR-b...

Bechien U. Wu, T. Luong, Eva Lustigova et al. · 0 citations
Open access Sep 2026

Predicting disease progression and mortality in prostate cancer using real-world data-driven time-inhomogeneous Markov models

Summary Prostate cancer progression varies across patients. Understanding disease trajectories and mortality risk is important for improved healthcare. This study developed a time-inhomogeneous Markov model using territory-wide electronic medical records from Hong Kong to estimate 10-year disease progression. The model...

Jia-Qi Wang, Yuan-Shi Jiao, D. Craig et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.